The HSF1 transcription factor is an integrator of the cellular stress response and its expression has demonstrated poor prognosis in multiple myeloma. Novel anti-HSF1 small molecule inhibitors CCT251236 and KRIB11 demonstrate in vitro and in vivo anti-myeloma activity, representing a novel approach for targeting the heat shock response in myeloma.
from Cancer via ola Kala on Inoreader http://ift.tt/2simVhv
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου